Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers
Clinical trial NCT05131919 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05131919
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2030-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.